Sn. Sanghavi et al., Radiosurgery for patients with brain metastases: A multiinstitutional analysis, stratified by the RTOG recursive partitioning analysis method, INT J RAD O, 51(2), 2001, pp. 426-434
Citations number
24
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To estimate the potential improvement in survival for patients wit
h brain metastases, stratified by the Radiation Therapy Oncology Group (RTO
G) recursive partitioning analysis (RPA) class and treated with radiosurger
y (RS) plus whole brain radiotherapy (WBRT).
Methods and Materials: An analysis of the RS databases of 10 institutions i
dentified patients with brain metastates treated with RS and WBRT. Patients
were stratified into 1 of 3 RPA classes. Survival was evaluated using Kapl
an-Meier estimates and proportional hazard regression analysis. A compariso
n of survival by class was carried out with the RTOG results in similar pat
ients receiving WBRT alone.
Results: Five hundred two patients were eligible (261 men and 241 women, me
dian age 59 years, range 26-83). The overall median survival was 10.7 month
s. A higher Karnofsky performance status (p = 0.0001), a controlled primary
(median survival = 11.6 vs. 8.8 months, p = 0.0023), absence of extracrani
al metastases (median survival 13.4 vs. 9.1 months, p = 0.0001), and lower
RPA class (median survival 16.1 months for class I vs. 10.3 months for clas
s II vs. 8.7 months for class III, p = 0.000007) predicted for improved sur
vival. Gender, age, primary site, radiosurgery technique, and institution w
ere not prognostic. The addition of RS boosted results in median survival (
16.1, 10.3, and 8.7 months for classes I, II, and III, respectively) compar
ed with the median survival (7.1, 4.2, and 2.3 months, p < 0.05) observed i
n the RTOG RPA analysis for patients treated with WBRT alone.
Conclusion: In the absence of randomized data, these results suggest that R
S may improve survival in patients with BM. The improvement in survival doe
s not appear to be restricted by class for well-selected patients. (C) 2001
Elsevier Science Inc.